![Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/371/2/487/F1.large.jpg)
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics
![Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/56/3/351/F1.large.jpg)
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
![Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors | Behavioral and Brain Functions | Full Text Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors | Behavioral and Brain Functions | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1744-9081-3-49/MediaObjects/12993_2007_Article_117_Fig5_HTML.jpg)
Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors | Behavioral and Brain Functions | Full Text
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)